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Most studies on the skin focus primarily on the hair follicle and interfollicular epidermis,
whereas little is known regarding the homeostasis of the sebaceous gland (SG). The SG has
been proposed to be replenished by different pools of hair follicle stem cells and cells that
resides in the SG base, marked by Blimp1. Here, we demonstrate that single Blimp1+ cells
isolated from mice have the potential to generate SG organoids in vitro. Mimicking SG
homeostasis, the outer layer of these organoids is composed of proliferating cells that
migrate inward, undergo terminal differentiation and generating lipid-filled sebocytes. Per-
forming confocal microscopy and mass-spectrometry, we report that these organoids exhibit
known markers and a lipidomic profile similar to SGs in vivo. Furthermore, we identify a role
for c-Myc in sebocyte proliferation and differentiation, and determine that SG organoids can
serve as a platform for studying initial stages of acne vulgaris, making this a useful platform to
identify potential therapeutic targets.
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The sebaceous gland (SG) is a holocrine-secreting appen-dage within the epidermis that functions as a crucialcomponent of the pilosebaceous unit1. In contrast to the
cyclic nature of the hair follicle (HF), the SG undergoes con-
tinuous replenishment during which proliferating cells situated at
the basal layer move inward to generate lipid-filled sebocytes1. As
differentiated sebocytes mature, they gradually accumulate lipids
and are driven toward the necrotic zone of the SG, where they
erupt and release their sebum1. Interestingly, the lipid content of
the sebum is species specific and in humans changes significantly
at different ages2.
Although SGs play a central role in skin homeostasis, little is
known regarding the mechanisms regulating their maintenance,
and how their dysregulation may contribute to certain skin
pathologies. One of the most widespread dermatological condi-
tions, acne vulgaris, involves multiple factors including dysregu-
lation of the SGs2. The pathogenesis of this disease includes
hyperactivation of SGs, excessive keratin deposition and an
increase in SG size, which is dependent upon sebocyte hyper-
proliferation and sebum production. This serves as an ideal lipid-
rich environment for Cutibacterium acnes (C. acnes; formerly P.
acnes) to flourish, which in turn triggers inflammation via the
induction of pro-inflammatory cytokines2. Notably, SGs can give
rise to additional pathologies including SG carcinomas, which can
metastasize and result in high mortality1. Thus, there is a great
need for generating an ex vivo model for specifically studying and
manipulating the SG in a three-dimensional (3D) setting.
The SG has been proposed to be replenished by distinct pools
of stem cells or progenitors located in the HF or base of the SG3–
7. A cellular population that has been reported to govern SG
homeostasis in mice is defined by the expression of B-
lymphocyte-induced nuclear maturation protein 1 (Blimp1)3.
Blimp1+ cells reside at the base of the SG and have been reported
to function as a sebocyte progenitor population3. Alternatively, it
has recently been suggested that Blimp1 functions in terminally
differentiated sebocytes8 as well as in granular IFE cells9, 10. These
reports prompted us to examine whether Blimp1+ cells cultured
in the proper conditions have the capacity to replenish, as well as
potentially generate, SG in vitro.
Here, we show that Blimp1+ cells isolated from adult mice
have the potential to generate SG organoids that recapitulate the
features of SGs in vivo. Utilizing this platform, we find that c-Myc
regulates both sebocyte proliferation and differentiation as seen in
normal SGs. Furthermore, using these organoids we are able to
generate a model that recapitulates aspects of acne vulgaris,
demonstrate the effects of currently available acne treatments as
well as elucidate c-Myc as a potential therapeutic target. Taken
together, here we describe a system that can be employed to study
the biology of the SG along with a drug screening platform for SG
pathologies.
Results
Generation of SG-like structures from mouse Blimp1+ cells.
We initially examined the distribution of Blimp1+ cells in the
mouse skin by employing B6.Cg-Tg(Prdm1-EYFP)1Mnz/J repor-
ter mice (denoted Blimp1-YFP)11. Performing confocal Z-stack
analyses, we discovered that Blimp1 is expressed in cells found at
the base of the SG, as well as in differentiated SG cells and
interfollicular epidermal (IFE) granular cells (Fig. 1a and Sup-
plementary Fig. 1a). These findings suggest that Blimp1 does not
mark a distinct cell population but is expressed in SG progenitors,
mature sebocytes, and differentiated IFE cells, as recently
reported3, 8–10.
Next, we performed fluorescence-activated cell sorting (FACS)
employing Blimp1-YFP reporter mice and antibodies against
integrin α6 (epidermal keratinocytes) and ScaI (IFE and
infundibulum cells). Thereby, α6+;ScaI−;Blimp1-YFP+ cells were
isolated from 8-week-old mice skin in second telogen (Fig. 1b).
Additionally, we could examine the morphology of Blimp1-YFP+
cells by performing flow cytometry coupled with high-resolution
microscopy (ImageStream), verifying that these cells highly
express YFP (Fig. 1c and Supplementary Fig. 1b). Furthermore,
using this approach, and in accordance with our previous
findings, we detected three morphologically distinct groups: (I)
small cells with high circularity, (II) large cells resembling mature
sebocytes, and (III) differentiated IFE keratinocytes (Supplemen-
tary Fig. 1b). Isolated α6+;ScaI−;Blimp1-YFP+ cells were then
expanded on J2 feeder cells for several passages in 2D culture
(Supplementary Fig. 1c), ensuring post-mitotic/terminally differ-
entiated SG/IFE cells were completely excluded. Next, we
examined whether embedding cells in a basement membrane-
like extracellular 3D environment such as Matrigel, which has
been successfully utilized in several epithelial stem cell platforms,
could enable establishment of SG organoids (Fig. 1d)12–14.
Additionally, we supplemented 3D Matrigel cultures with a
custom-made media for epidermal cells15. In particular, since
epithelial cells are extremely sensitive to calcium, bovine serum
was chelated and cells were grown in 50 mM of Ca2+. Given that
several key signaling cascades are known to regulate the function
and expansion of epithelial cells in the pilosebaceous unit we also
supplemented our culture media with EGF, hFGF-2, Noggin, and
R-spondin1 (EFNR). Specifically, we used hFGF-2 as it can drive
sebocyte proliferation and hypertrophy16, EGF was administered
as it enhances sebocyte proliferation, enlarges SGs and increases
sebum production17 as well as R-spondin1, which promotes Wnt
signaling that drives SG generation18. We also administered the
BMP inhibitor Noggin1 as it has been reported to regulate
sebocyte differentiation19.
Within one day, we could clearly detect that isolated α6+;ScaI
−;Blimp1-YFP+ cells had undergone cellular division (Fig. 1e).
Strikingly, within 12 days, seeded single cells could generate large
spheroid structures, which highly resembled the morphology of a
SG in vivo (Fig. 1e). In contrast, when cells were grown without
EFNR factors in 3D culture, growth was significantly impaired
and only a very limited number of organoids were generated
(Supplementary Fig. 1d, e). Of note, a large number of organoids
could be generated at a high efficiency (~32% of plated cells) even
after multiple passaging (~40 passages) in vitro (Fig. 1f).
Examining the morphology of developed (10-day old)
organoids exposed a defined ring of compact cells at the outer
layer, as well as larger cells of varying sizes in the inner mass
that appeared reminiscent of differentiated sebocytes (Fig. 1g
and Supplementary Fig. 1f, Supplementary Movie 1). Notably,
when α6+;CD34+ HFSCs were grown in similar conditions we
did not observe the formation of these structures. These
cultures resulted in non-organized spheroid clusters highly
similar to those recently reported20 (Supplementary Fig. 1g).
Additionally, under these condition α6+;ScaI+ IFE/infundibu-
lum cells did not give rise to any defined cellular structure
(Supplementary Fig. 1h).
We next examined if we could generate Blimp1+ cell-derived
organoids by isolating primary α6+;ScaI−;Blimp1-YFP+ cells and
directly seeding them into Matrigel without a pre-culturing phase.
These attempts did not give rise to organoid structures
presumably due to low cell survival through loss of cell–cell
contact. Thus, we supplemented these cultures with the ROCK
inhibitor (Y27632), which prevents cell–cell interaction-
dependent anoikis21. Under these culture conditions freshly
isolated α6+;ScaI−;Blimp1-YFP+ cells were able to give rise to
organoids, albeit at a lower efficiency (Supplementary Fig. 1i, j).
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SG organoids recapitulate SG features. In the SG, cell pro-
liferation is restricted to basal cells, which reside at a defined
region known as the SG proliferative zone (SGPZ). During SG
homeostasis, SGPZ cells migrate inward, become post-mitotic
and differentiate to lipid-filled sebocytes (Fig. 2a)1, 22.
In order to examine whether these organoid structures
recapitulate normal SGs, we first performed immunofluorescence
(IF) with the proliferative marker, Ki67, known to mark cells of
the SGPZ1, 23. As expected, analysis of skin wholemounts showed
that Ki67 is specifically expressed in the outer layers of the SG
and could rarely be seen in quiescent bulge HFSCs in vivo
(Fig. 2b). Quantitative analysis indicated that ~34% of cells in the
SGPZ were positive for Ki67. Similarly, Ki67+ cells could be
detected in the outer layer of Blimp1+ cell-derived organoids at a
similar frequency (Fig. 2c and Supplementary Fig. 2a). These



























































Fig. 1 Single Blimp1+ cells generate sebaceous gland-like structures ex vivo. a Representative image of dorsal skin wholemount extracted from P56
(telogenic)-old B6.Cg-Tg(Prdm1-EYFP)1Mnz/J (denoted Blimp1-YFP) mouse stained for Oil Red O (ORO). Blimp1-YFP+ signal (yellow arrows) can be seen at
the base of the sebaceous gland (SG) [n= 5 mice]. b Fluorescent-activated cell sorting (FACS) analysis employing Blimp1-YFP reporter mice demonstrating
the α6+;Sca1-;Blimp1-YFP+ (Blimp1-YFP+) population [n= 5 pooled mice]. c Image stream analysis showing representative brightfield (BF) images of
Blimp1-YFP+ cells, indicating that these cells display three distinct morphologies: (1) small cells with high circularity, (2) large cells resembling sebocytes,
and (3) differentiated keratinocytes. d Schematic diagram representing the process of Blimp1-YFP+ cell-derived organoid generation. e Representative
images of initial single seeded Blimp1-YFP+ cell maintained in 3D culture for a period of 12 days. Scale bar is relative to all images shown for each day. f
Single-cell suspension of Blimp1-YFP+ cells, supplemented with growth factors, form a large number of organoids after a period of 1 week. g Representative
3D-reconstructed confocal image of an organoid after 10 days in culture stained for actin. Left panel shows an external view of a layer of compact similarly
sized cells, while the right panel demonstrates cross-section of large inner cells of varying sizes. All experiments were repeated at least three times with
similar results. Organoids were grown from a mix of at least three mice and cultured in three independent biological repeats. Scale bars: 10 μm (c), 20 μm
(a, e), 50 μm (g), 100 μm (f, f inset)
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(Fig. 2d and Supplementary Fig. 2b). Notably, alike in vivo, we
could not detect proliferating cells within the inner mass of the
organoids (Supplementary Fig. 2c, d).
A key component of the cytoskeleton of epithelial cells is
Keratin 5 (K-5), which is primarily expressed in basal keratinocytes
of the epidermis24. Similar to SGs in vivo, Blimp1+ cell-derived
organoids expressed K-5 in the outer layer (Fig. 2e and
Supplementary Fig. 3a, b). Performing IF in both dorsal and tail
wholemounts with K-15 antibody, we found that it labels specific
cells at the base of the SG and junctional zone, as well as
individual cells in the outer layer of the organoids (Fig. 2e and
Supplementary Fig. 3a, c).
Similar to the in vivo expression pattern of Blimp1, marking
cells at the base of the SG as well as mature sebocytes (Fig. 1a and
Supplementary Fig. 1a–c), Blimp1-YFP+ cells could be seen in
both locations in the mature organoid (Supplementary Fig. 3d, e).
These findings indicate that the Blimp1 promoter is active in
organoids, supplying further evidence for the similarity to
natural SGs.
Since proliferating cells could only be seen on the outer layer of
organoids, we investigated whether they could give rise to cells in
the inner compartment by monitoring movement kinetics.
Conducting pulse-chase 5-bromo-2′-deoxyuridine (BrdU) experi-
ments, we found that 24 h after the pulse only cells located on the
organoid outer layer were positive for BrdU (Fig. 2f and
Supplementary Fig. 4a). This finding is in accordance with our
Ki67 and MCM2 staining (Fig. 2c, d). In contrast, after 48 and 72
h we could clearly detect BrdU+ cells in the inner non-
proliferating mass, indicating that cells from the outer layer
either migrated or proliferated asymmetrically and gave rise to
differentiated post-mitotic cells (Fig. 2g, h and Supplementary
Fig. 4b, c).
In order to investigate the movement kinetics in real time, we
performed time lapse imaging using light sheet microscopy. First,
Blimp1-YFP+ cells were infected with retroviruses encoding H2B-
GFP, which fluorescently labels the nucleus. Organoids were then
grown for 7 days, followed by visualization for 24 h. Our results
indicate that the majority of cellular divisions, estimated at above
90%, occurred along the peripheral ring. However, we could also
clearly detect asymmetrical divisions, although at a markedly
lower occurrence (Fig. 2i and Supplementary Fig. 4d–f;
Supplementary Movie 2). Thus, our data indicate that Blimp1+
cell-derived organoids mimic both the expression profile and
homeostatic kinetics of SGs in vivo.
SG organoids display the SG in vivo lipidomic profile. One
distinct feature of a SG is the distinct profile of lipids that it
generates25–27. Using the lipid dye Oil red O (ORO), we found
that Blimp+ cell-derived organoids encompass lipid-producing
cells in the inner mass (Fig. 3a). The observations that inner
organoid cells do not proliferate and express lipids is suggestive of
a differentiation program similar to that of a SG in vivo. There-
fore, in order to examine whether these organoids generate
comparable lipids to a normal SG, we performed lipidomic
analysis utilizing high-performance liquid chromatography
(HPLC) coupled with mass-spectrometry (LC/MS). We per-
formed a comparison of lipid composition between: (1) whole
epidermis, (2) resected SGs, (3) Blimp1+ cell-derived organoids,
and (4) Blimp1+ cells grown in 2D culture. Additionally, we
included highly unrelated samples: HEK293T cells and mouse
brain. Lipids were extracted in three biological replicates by Folch
procedure28 and were subjected to C18 chromatographic
separation, coupled with electrospray ionization high-resolution
MS analysis (Fig. 3b). We identified 6470 peaks representing
single-charged molecular ions in both polarity modes ([M+H]+,
[M+NH4]+, [M-H]−, [M+HCO2]−). Large classes of lipids
were observed as series of peaks separated by the mass (m/z) of
C2H4 segment with a shift to longer retention times (RT) for
longer acyl chains and higher saturation levels (Fig. 3c). We used
normalized intensity profiles of identified lipid compounds to
quantify content similarity between samples. Next, similarity in
the total lipidome was assessed by hierarchical clustering (Fig. 3d)
and principle component analysis (PCA; Fig. 3e). Hierarchical
clustering grouped together resected SGs, Blimp1+ cell-derived
organoid samples and 2D-grown Blimp1+ cells, while
HEK293T cells/brain and epidermis represented two additional
distinct groups (Fig. 3d, e). A significant portion of detected lipids
could then be grouped based on their elevated relative abundance
within a combination of sample types: SGs, Blimp1+ cell-derived
organoids and 2D-grown Blimp1+ cells (cluster I), epidermis,
SGs, and Blimp1+ cell-derived organoids (cluster II) and epi-
dermis, HEK293T cells and brain (cluster III; Fig. 3d). Of note,
cluster III was clearly distinguishable from the SGs/organoids/
Blimp1+ cells (cluster I) profile (Fig. 3d). In our analysis we could
detect the production of a specific spectrum of lipids in both
normal SGs and in Blimp1+ cell-derived organoids (Fig. 3d).
The PCA analysis of the MS data further supported lipidome
characterization, by placing the first principle component (PC1)
as a direction differentiating SGs, Blimp1+ cell-derived organoids
and 2D-grown Blimp1+ cells from the epidermis and
HEK293T cells/brain group of samples (Fig. 3e). The second
principle component (PC2) differentiated samples of brain/HEK
versus epidermis and SGs/organoids/Blimp1+ samples. The first
two principle components together explain more than half of the
variance in the data. On the PCA score plot, SGs/organoids/
Blimp1+-specific compounds are distinctly separate from the
groups of epidermis and HEK293T cells/brain-specific com-
pounds (Fig. 3e). The density distribution of PCA scores is
represented by a landscape with deep valleys separating the SGs/
organoids/Blimp1+-specific peaks versus all others, indicating the
distinction and the strong cross correlation of the SG-like lipids
(Fig. 3f). Taken together, our lipidomic analysis indicates that SG
organoids have the capacity to generate specific lipids, displaying
a signature resembling that of SGs in vivo.
c-Myc functions as a key regulator of SG organoids. Given that
Blimp1+ cell-derived organoids displayed morphological and
functional similarity to normal SGs, we next examined if this
Fig. 2 Blimp1-YFP+ cell-derived organoids express sebaceous gland markers. a Schematic view of the sebaceous gland structure and various cell type
markers. b Tail skin wholemount extracted from P56 (telogenic)-old wild type (WT) mouse stained for Keratin-15 (K-15) and Ki67. c, d Confocal analysis of
Blimp1-YFP+ generated organoids cultured for 10 days, stained for (c) Ki67 and (d) MCM2, showing proliferating cells in the outer layer. e Confocal
analysis of Blimp1-YFP+-generated organoids cultured for 10 days, stained for K-15 and K-5. f–h BrdU pulse-chase analysis for (f) 24 h, (g) 48 h, and (h) 72
h showing migration of BrdU-labeled cells from the outer layer to the inner non-proliferating mass. i Representative time points of live imaging of
movement kinetics, utilizing light sheet fluorescence microscopy, examining 7-day-old organoids derived from Blimp1-YFP-H2B-GFP+ (nuclear labeled)
cells over a 24 h period. Two tracked cells and their progeny (blue and red dots) over time are marked. All images are representative of at least n= 3 mice.
In vitro experiments were repeated at least three times with similar results. Organoids were grown from a mix of at least three mice and cultured in three
independent biological repeats. Scale bars: 10 μm (i), 20 μm (b–e), 50 μm (f–h)
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platform could be utilized to investigate signaling cascades that
regulate SG homeostasis. One pivotal factor that governs SG
expansion is c-Myc3, 29, 30. In an in vivo setting, c-Myc labels cells
in the SGPZ and regulates both sebocyte proliferation and dif-
ferentiation31 (Supplementary Fig. 5a). Alike normal SGs, we
found that the expression of c-Myc mostly co-localized with Ki67
and MCM2 in the SGPZ and, as expected, could not be detected
in the inner compartment of the SG organoids (Supplementary
Fig. 5b, c).
To monitor the effect of inhibiting c-Myc activity we
administered the specific c-Myc inhibitor, 10058-F4, which
prevents the c-Myc-Max interaction and inhibits transcription
of c-Myc target gene expression32. Six-day-old SG organoids were
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~40% decrease in organoid size (Fig. 4a, b and Supplementary
Fig. 6a). Since the effect on organoid size could result from either
altered cell size or number, we examined both these possibilities.
Quantifying the diameter of individual cells in the outer
proliferating layer of the organoid suggested a modest size
decrease (Fig. 4c). However, inhibition of c-Myc had a strong
effect on the diameter of cells in the inner compartment, resulting
in a ~40% decline in cell diameter size (Fig. 4b, c). In
complement, we found that the number of cells in the outer
ring of the c-Myc-inhibited organoids had decreased, encom-
passing cells of smaller size in the inner zone (Fig. 4b, c and
Supplementary Fig. 6b, c).
We next examined whether the effect of c-Myc inhibition
originates from an effect on cell proliferation and/or differentia-
tion. IF staining against Ki67 and MCM2 indicated a significant
decline in Ki67+ (69%) and MCM2+ (72%) proliferative cells
(Fig. 4d, e and Supplementary Fig. 6d). This suggests that
proliferation and expansion of the SG organoids is dependent
upon c-Myc activity. Our data indicated that, upon c-Myc
inhibition, cells in the inner compartment were significantly
smaller than their control counterparts, suggesting a possible
effect on cell differentiation. Accordingly, c-Myc has been
reported as a key regulator of differentiation in the SG
in vivo31, 33. Initially, we performed lipid staining with the
ORO dye, which demonstrated a significant decrease in lipid
levels (Fig. 4f and Supplementary Fig. 6e). Using real time (RT)-
PCR analysis, we examined mRNA levels of transcripts expressed
in SG differentiating or differentiated cells, which play a key role
in lipid production22. Inhibition of c-Myc decreased the levels of
all examined factors, including androgen receptor (AR) and fatty
acid synthase (FASN) (Fig. 4g). Furthermore, the central
transcription factors peroxisome proliferator-activated receptor-
ß and peroxisome proliferator-activated receptor-γ (PPAR-ß and
PPAR-γ), which govern numerous genes involved in lipid
synthesis and regulation of sebocyte differentiation and matura-
tion22, were also significantly attenuated (Fig. 4g). These data
show that, like normal SGs, c-Myc plays an instrumental role in
regulating both proliferation and differentiation of the Blimp1+
cell-derived organoids.
SG organoids as a platform for studying initial stages of acne
vulgaris. We next sought out to examine whether these organoids
could be utilized for the study of SG pathologies. Since acne
vulgaris effects millions of lives worldwide, we first attempted to
generate the conditions where the SG organoids potentially
exhibit key aspects of this pathology. Acne vulgaris is character-
ized by excessive keratin deposition and an increase in SG size,
which is dependent upon sebocyte hyperproliferation and sebum
production. This serves as an ideal lipid-rich environment for C.
acnes to flourish which in turn triggers inflammation via the
induction of pro-inflammatory cytokines2.
Androgen stimulation has been found to play a critical role in
regulating sebocyte proliferation and driving the emergence of
acne2, while PPARs have been shown to alter sebaceous lipid
production and modulate acne formation34, 35. Therefore, we
examined whether we could generate an organoid platform that
exhibits key aspects of acne formation, without the presence of C.
acnes and an inflammatory response, simply by androgen and
PPAR stimuli. As a first step, we administered the potent
dihydrotestosterone (DHT) androgen, the PPAR-γ BRL-49653
(BRL) activator and linoleic acid (LIN) known to activate PPAR-
ß36. Administration of BRL, LIN, or DHT for 7 days significantly
increased the size of individual SG organoids. While dual
combinations did not have an additive effect on organoid size,
the combined administration of DHT, BRL, and LIN (denoted
DBL) resulted in significantly larger organoids (Fig. 5a, Supple-
mentary Fig. 7a). In accordance, treatment with DBL led to the
most considerable increase in mRNA levels of AR, FASN, PPAR-
ß, and PPAR-γ, suggestive of increased lipid synthesis (Supple-
mentary Fig. 7b).
In order to assess whether sebum production was indeed
affected in response to DBL treatment we performed ORO
staining and observed a significant increase in the number of
ORO+ cells (Fig. 5b and Supplementary Fig. 7c). Of note, as in
control organoids and normal SGs, all ORO+ cells were located in
the inner differentiated part of the DBL-treated organoids
(Fig. 5b). To examine whether proliferation was also affected
we performed staining against Ki67 and detected a significant
increase in the numbers of Ki67+ cells upon DBL treatment
(Fig. 5c). These results were verified by RT-PCR analysis,
indicating the most significant increase in levels of c-Myc and
Cyclin D1 transcripts upon DBL treatment (Supplementary Fig.
7d). Taken together our findings indicate that administration of
specific androgens and PPAR-stimulators can result in an
organoid model that recapitulates initial key aspects of acne
development including altered sebocyte proliferation, increase in
sebum production, and augmented organoid size.
Since we were able to generate a system that recapitulates key
aspects of acne vulgaris, we next examined the extent that
currently prescribed medications could affect its development.
Retinoids are derivatives of vitamin A, which serve as the first-
line treatment for acne2. Specifically, all-trans-retinoic acid
(ATRA; Tretinoin), formulated ATRA (Ret-Avit), and 13-cis
RA (Isotrtinoin) are used worldwide2. Administration of all three
retinoids to DBL-treated organoids resulted in a significant
decrease in organoid size with formulated ATRA yielding the
most robust results (Fig. 5b and Supplementary Fig. 7e).
Furthermore, retinoid administration instructed cell differentia-
tion leading to a heightened number of ORO+ cells (Fig. 5b).
Fig. 3 Lipidomic analysis of Blimp1-YFP+ cell-derived organoids. a Blimp1-YFP+-derived organoid grown for 14 days. Lipids are stained with Oil red O (ORO).
b Sebaceous gland (SG) sample base peak chromatogram. Lipids specifically abundant in the three SG-like samples: (1) extracted SGs (denoted SG), (2)
Blimp1+ cell-derived organoids (SG Org), and (3) 2D-grown Blimp1+ cells (Blimp1) are marked in red [n= 3 independent biological samples]. Several most
abundant lipids are marked blue. c Representative mz/rt map for triacylglycerides (TGs) peak positions across all superimposed LC/MS samples. Each dot
represents the center of a peak group for an identified TG compound. Arrows join peaks separated by mass difference of C2H4 fragment (5 ppm mass
precision) sharing the same number of double bonds. d Normalized intensities of lipid compounds identified in the samples. Eighteen columns are arranged
by unsupervised hierarchical clustering, while rows are composed according to k-means clustering outcome (three clusters: SG/SG-Org/Blimp (cluster I;
red), epidermis/SG/SG-Org (cluster II; green), and epidermis/HEK293T cells (HEK)/brain (cluster III; blue). For each sample type, three biological
replicates were analyzed. e PCA loadings plot shows three major directions identified among samples accounting for 75% of total variance. The main effect
is associated with SG features, where loadings are close between SG, SG Org, and Blimp1 samples. The second strongest effect is epidermis-like profile,
where loadings are close between epidermis and SG features. f Density plot of PCA scores shows separation of total lipidome into two major groups of
compounds: SG-specific and the rest of the lipids, as highlighted by color. Density of scores shows non-continuous distribution supporting distinct lipidome
profiles for the denoted groups of samples. Scale bar: 50 μm (a)
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Interestingly, in these conditions we could also detect ORO+ cells
along the SGPZ, suggestive of an altered differentiation program.
The differentiation program in the SG is a multi-step process33.
Cells prior to the onset or during early stage of differentiation
express AR, which is known to reside upstream and lead to the
expression of FASN33. In response to the different retinol
treatments, we could detect a significant decrease in the mRNA
levels of AR and FASN, indicating that early differentiating cells
were not abundant in these organoids (Fig. 5d). Additionally, the
mRNA level of PPAR-ß was also significantly decreased (Fig. 5d).
Interestingly, the level of PPAR-γ, which is known to be
expressed during middle/late differentiation, was significantly
increased (Fig. 5d). This result, in combination with the high
numbers and location of ORO+ cells, suggests that retinol
treatments can advance and alter the differentiation process. In
addition to increased differentiation, we found that all retinol
treatments led to a drastic decrease in proliferation levels as










































































Fig. 4 c-Myc regulates proliferation and differentiation in SG organoids. a Blimp1-YFP+-derived sebaceous gland organoids cultured for 6 days and treated
for 4 days with c-Myc inhibitor 10058-F4 or DMSO as control. Cross-section of control and treated organoids stained for actin. b Treated organoids display
decreased organoid size in comparison to control organoids. c Cell size analysis of treated and control organoids measuring cell diameter of inner cells and
cells at the outer layer [n= 80 individual organoids in three independent wells]. d, e Confocal analysis of treated and control organoids stained with (d)
Keratin-5 (K-5) and Ki67 and (e) MCM2, showing dramatic decrease in proliferating cells upon c-Myc inhibition. f Control and treated organoids stained
for Oil Red O (ORO), showing diminished differentiation upon c-Myc inhibition. g Quantitative real time (RT)–PCR analysis of treated organoids. mRNA
levels of known sebocyte differentiation markers including androgen receptor (AR), fatty acid synthase (FASN), and peroxisome proliferator-activated
receptors beta and gamma (PPAR-β,ɣ) are significantly decreased upon c-Myc inhibition. Changes in cycle threshold values were normalized to Rplp0.
Data are represented as mean relative to control organoids [n= 3 independent wells analyzed in triplicates]. Error bars show ± s.e.m. Significance was
determined using two-tailed unpaired Student’s t-test, where *p < 0.05, **p < 0.005, ***p < 0.001. All images are representative of organoids grown from a
mix of at least three mice and cultured in three independent biological repeats. All experiments were repeated at least three times with similar results.
Scale bars: 50 μm (b, d–f), 100 μm (a)
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and RT-PCR analysis examining the mRNA levels of Cyclin D1
and c-Myc.
Retinoids, such as 13-cis RA, are known to have severe side-
effects and concerns have been raised regarding the teratogenicity
of these compounds22. This highlights the need for alternative
treatments. Interestingly, a recent genome wide association study
of severe teenage acne has suggested c-Myc as a potential
regulator37. Therefore, we hypothesized that inhibition of c-Myc
could serve as a beneficial treatment of acne vulgaris. For this aim,
we administered the 10058-F4 c-Myc inhibitor to DBL-treated
organoids and monitored size, proliferation, and differentiation.
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significant decrease in organoid size similar to that of retinol
treatment (Fig. 5e and Supplementary Fig. 8a). Interestingly, c-
Myc inhibition led to a substantial decrease in ORO+ cells (Fig. 5f
and Supplementary Fig. 8b). Moreover, we found a decrease in
the size of individual inner cells (Supplementary Fig. 8c) and
significantly lower expression levels of lipid synthesis genes,
indicative of diminished differentiation (Fig. 5g). Finally, we
monitored cellular proliferation and found a more than 80%
decrease in the number of Ki67+ cells, correlating to a substantial
decrease in the levels of Cyclin D1 and c-Myc transcripts (Fig. 5g
and Supplementary Fig. 8d).
Taken together, these results indicate a potential role of c-Myc
in the pathogenesis of acne vulgaris and suggest that it may be
utilized as a therapeutic target.
Discussion
In this work, we have generated an organoid model that recapi-
tulates critical aspects of SG biology, which could serve as a tool
to study the SG in homeostasis and different pathologies. To
achieve this goal, we first set out to establish which cells have the
capacity to give rise to a SG mini-organ in vitro. In the past,
elegant studies have reported conflicting findings as to which cells
within the mouse epidermis express the Blimp1 marker. Initially,
it was reported that Blimp1+ cells reside exclusively at the base of
the SG and serve as a pool of progenitors3. Subsequently, it was
described that terminally differentiated sebocytes8, as well as
granular layer IFE keratinocytes9, 10 are marked by the Blimp1
protein. Here, by performing advanced 3D confocal analyses and
coupling flow cytometry with high-resolution microscopy, we
have been able to reconcile these observations and demonstrate
that Blimp1 marks cells which reside in each of these locations.
Notably, in contrast to terminally differentiated sebocytes and IFE
keratinocytes which are post-mitotic, we have been able to
expand Blimp1+ cells in 2D for extended periods of time, which
serves as an indication for their progenitor and stemness features.
We established the in vitro conditions required for the gen-
eration of SG organoids by embedding Blimp1+ cells in a 3D
environment and supplementing the cultures with key factors,
known to regulate different aspects of SG biology. These condi-
tions can be easily applied and enable the establishment of SG
organoids. Our detailed analyses indicated that Blimp1+ cell-
derived organoids mimic both the expression profile and
homeostatic kinetics of SGs in vivo. Additionally, these organoids
encompass lipid-producing cells in the inner mass and by uti-
lizing HPLC coupled with LC/MS we demonstrate that SG
organoids display a lipid signature resembling that of SGs in vivo.
A fundamental factor that governs SG expansion in vivo is c-
Myc3, 29–31,. By utilizing SG organoids, we found that c-Myc is
only expressed in proliferating SGPZ cells and not in the inner
differentiated compartment. Inhibition of c-Myc activity resulted
in a significant decrease in cell proliferation and organoid size.
Furthermore, c-Myc inhibition had a strong effect on sebocyte
differentiation as well as on the size of differentiated inner-
organoid sebocytes. These results are in accordance with pre-
viously reported findings where overexpression of c-Myc led to
enhanced SG expansion, while conditional deletion of c-Myc
resulted in decreased SG size, cell proliferation, and sebocyte
differentiation3, 29, 38, 39. Notably, Blimp1 has been shown to
govern the size of SGs by repressing c-Myc gene expression3.
Thus, it will be interesting to examine which additional factors
can regulate the activation and expression of c-Myc. As SG
organoids capture the complex function of c-Myc, we hypothesize
that this platform can be utilized for investigating various
molecular circuits governing SG homeostasis and development.
Acne vulgaris is a chronic disease of the pilosebaceous unit
resulting from androgen-induced increased sebum production40.
Some of the key features of acne development include disturbed
SG activity resulting in excessive sebum, altered sebocyte pro-
liferation and differentiation, dysregulation of the hormonal
environment, hyperkeratinization, colonization of C. acnes and
inflammation2, 40.
Utilizing our SG platform we were able to generate features of
acne. We administered the organoids with PPAR activators and
the potent androgen, DHT, which are known to lead to hyper-
seborrohoea and increased sebcote proliferation2. This resulted in
organoids that grew substantially in size and were characterized
by excessive sebum production, increased sebocyte proliferation,
and altered differentiation.
Of note, key aspects of acne vulgaris include C. acnes coloni-
zation and the induction of an inflammatory response which are
not present in our model. In this regard, since it has been shown
that C. acnes upregulates the expression of pro-inflammatory
cytokines in cultured sebocytes2, it may be interesting to examine
such an effect in the organoid platform. As additional bacterial
strains are suspected to play a role in the development of acne41,
our system enables examination of their function and contribu-
tion to this process.
It has been proposed that, as acne vulgaris is solely human
disease, it cannot be recapitulated by animal models. As we have
utilized mouse cells for establishing the SG organoid platform and
it lacks important stages in acne development, it is key to note
that it does not fully recapitulate a human model. Nevertheless,
we show that administration of currently available acne
Fig. 5 Sebaceous gland organoids can model the initial stages of acne vulgaris. a–d Blimp1-YFP+-derived sebaceous gland organoids cultured for 5 days and
treated for 3 days with a combination of DHT, BRL, LIN (DBL), or pure ethanol as control, followed by treatments for 3 days with retinoic acid (RA), 13-cis-
retinoic acid (13cis RA) or Ret-Avit (Tretinoin). a DBL-treated organoids display increased organoid size in compared to control organoids, which is reduced
upon treatments with retinoic acid derivatives. b Organoids stained for Oil Red O (ORO) show increased lipid production upon DBL treatment and retinoic
acid derivatives. c Confocal analysis of treated and control organoids stained with Ki67, showing increased proliferation upon androgen induction and
decreased proliferation in retinoic acid derivatives-treated organoids. d Quantitative real time (RT)-PCR analysis of treated organoids showing changes in
mRNA levels of cMyc, Cyclin D1, androgen receptor (AR), fatty acid synthase (FASN), and peroxisome proliferator-activated receptors beta and gamma
(PPAR-β,ɣ). e–h Blimp1-YFP+-derived sebaceous gland organoids cultured for 5 days and treated for 3 days with DBL combination as before, following
treatments for 3 days with c-Myc inhibitor 10058-F4. e c-Myc inhibitor-treated organoids display decreased organoid size in compared to DBL-treated
organoids. f Organoids stained for ORO, showing decreased lipid production upon c-Myc inhibition. g Confocal analysis of treated and control organoids
stained with Ki67, showing decreased proliferation in c-Myc-inhibited organoids. h Quantitative RT-PCR analysis of treated organoids showing changes in
mRNA levels of c-Myc, Cyclin D1, androgen receptor (AR), fatty acid synthase (FASN), and peroxisome proliferator-activated receptors beta and gamma
(PPAR-β,ɣ). In all RT-PCR experiments, changes in cycle threshold values were normalized to Rplp0. Data are represented as mean relative to control
organoids [n= 3 independent wells analyzed in triplicates]. Error bars show ± s.e.m. Significance was determined using two-tailed unpaired Student’s t-test
where *p < 0.05, **p < 0.005, ***p < 0.001. All experiments were repeated at least twice in triplicates with similar results and images are representative of
organoids grown from a mix of at least three mice and cultured in three independent biological repeats. Scale bars: 50 μm (a–c, e, f, h)
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treatments affected SG organoid size, proliferation, and differ-
entiation, akin to acne in vivo. Furthermore, this platform indi-
cated that c-Myc plays an important role in the pathology of acne
as recently suggested by a genome wide screen37. Our findings
suggest that c-Myc can potentially be used as a therapeutic target
for the treatment of acne thus indicating that our SG model can
potentially serve for the discovery of previously undescribed acne
therapeutics.
In summary, our findings bring forward a platform that may be
utilized for drug screening purposes, as well as for studying SG
homeostasis, functions, and pathologies.
Methods
Mice. All animal studies gained approval by the Committee on the Ethics of
Animal Experiments of the Technion-Israel Institute of Technology. B6.Cg-Tg
(Prdm1-EYFP)1Mnz/J mice were purchased from Jackson. All mice were bred and
housed in the Technion animal facility under specific pathogen-free conditions.
Mice were provided access to food and water ad libitum. Mice were sacrificed using
CO2 intoxication, in accordance with our institutional guidelines at 8 weeks of age.
Mice of both sexes were utilized for all analyses.
Flow cytometry. Dorsal skin from 8-week-old mouse was shaved and harvested.
Underlying adipose tissue was removed before incubting in trypsin overnight at 4 °
C or 2 h at 37 °C42. Epidermis and hairs were collected and filtered before sorting43.
Isolation of α6+ScaI−Blimp-YFP+ cells was performed using a BD FACSAria IIIu
sorter, sorting for endogenous Blimp1-YFP+ and utilizing antibodies against
Integrin α6 (eBioscience, #12-0495-82) and ScaI (BD Pharmigen, #558162). Amnis
ImageStreamX Mark II Flow cytometer was used to visualize Blimp-YFP
+-sorted cells.
Cell culture. α6+ScaI−Blimp-YFP+ cells were cultured in keratinocyte stem cell
medium44. Briefly, medium is prepared using Dulbecco’s modified Eagle medium
(DMEM)/F12 3:1 (Biological Industries) containing L-glutamine (Biological
Industries; 1:100), penicillin/streptomycin (Biological Industries; 1:100), 10% che-
lated fetal bovine serum, 5 µg/ml insulin (Sigma I-5500), 5 µg/ml transferrin (Sigma
T-2252), 2 × 10−12 M T3 (3,3′-triiodo-L-thyronine; Sigma T-2752), 400 ng/ml
hydrocortisone (Sigma H0888), cholera toxin 10−10 M and 50 mM CaCl2. Cells
were grown on sustaining J2 feeder cells for 4–6 passages until stable colonies were
formed, followed by culturing without feeders. For organoid generation a total of
~5000 cells were mixed with 50 μl of Matrigel (BD Bioscience) and plated in 24-
well plates. 500 μl of keratinocyte stem cell medium media containing growth
factors: 20 ng ml−1 hFGF (Peprotech), 40 ng ml−1 mEGF (Peprotech), 500 ng ml−1
hR-spondin 1, 100 ng ml−1 mNoggin (Peprotech), and B-27 Supplement (50×;
Invitrogen) was added after polymerization of Matrigel.
Treatment with c-Myc inhibitor 10058-F4 (100 µM, Tocris Bioscience) or
DMSO (as a control) was performed for 4 days and renewed upon media change.
5-Bromo-2′-deoxyuridine (BrdU; 1:1000 dilution, GE Healthcare) pulse-chase
experiments were performed by treating 6-day-old organoids for 8 h. For analyses,
organoids were fixed in 4% PFA for 1 h for IF or harvested for RNA extraction.
In order to establish conditions mimicking acne vulgaris, SG organoids cultured
for 5 days and treated for 3 days with DHT 10−5 M, BRL 10−6M, LIN 10−4 M
(Sigma Aldrich), or pure ethanol as control, following treatments for 3 days with
retinoic acid 100 µM (Sigma Aldrich), 13-cis-retinoic acid 100 µM (Sigma Aldrich),
or Ret-Avit (Tretinoin 0.05% w/w, final 10 µM) (CTS Chemical industries Ltd.)
Live imaging. Blimp1-YFP+ cells were infected with retroviruses LV-GFP
(Addgene, Plasmid #25999), which fluorescently labels the nuclear histones. From
these, infected organoids were generated for 7 days, followed by visualization using
light sheet fluorescence microscopy (LSFM) for a duration of 24 h. Analyses of the
data including cells division tracking was performed using Imaris Image Analysis
Software.
Histology and IF. For whole mount preparation, tail skin samples were treated
with 20 mM EDTA for 4 h at 37 °C to separate skin epithelium from dermis and
then fixed in 4% formaldehyde for 2 h at room temperature. Dorsal skin samples
were treated with 20 mM EDTA for 6 h at 37 °C to separate skin epithelium from
dermis and fixed in 4% formaldehyde for 1 h at room temperature.
Following fixation, samples were blocked for 2 h in blocking buffer consisting of
10% goat serum, 2% BSA, and 1% Triton-X. Primary antibodies were diluted in
blocking buffer and samples were incubated overnight at 4 °C. Samples were
washed at least three times with PBS. Secondary antibodies were incubated for 1 h
at room temperature followed by four washes with PBS.
The following primary antibodies were used: Ki67 (rabbit, 1:100, Abcam; rat,
1:100, eBioscience), MCM2 (rabbit, 1:500, Abcam), BrdU (mouse, 1:200, Santa
Cruz), c-Myc (mouse, 1:100, Santa Cruz), Phalloidin (1:250, Life Technologies), K-
15 (mouse, 1:100, Thermo; chicken, 1:1000, Abcam), and K-5 (rabbit, 1:500,
Abcam).
Secondary antibodies conjugated to Alexa Fluor-488, Alexa Fluor-546, and
Alexa Fluor-633 were used in order to visualize the primary antibodies. For lipid
visualization, Oil-red-O (ORO) staining was performed by incubating samples in
0.18% ORO in 60%isopropanol for 20 min, followed by three washes with PBS.
Imaging analyses were performed on a Zeiss LSM 880 confocal microscope.
RNA extraction and real-time PCR. RNA isolation was performed using TRIzol
reagent according to manufactures protocol (Sigma). Up to 2 μg of RNA were used
for cDNA production (Applied Biosystems). Quantitative real time (qRT)-PCR was
performed using the PerfeCTa SYBR Green FastMix (Quanta), with primers spe-
cific for the following genes: RpLp0: GCGACCTGGAAGTCCAACTA and
ATCTGCTTGGAGCCCACAT3, AR: AGAATCCCACATCCTGCTCAA and
AAGTCCACGCTCACCATATGG, PPAR-gamma: GATGGAAGACCACTC
GCATT and AACCATTGGGTCAGCTCTTG, PPAR-beta: TTCCTTCCAGCAG
CTGTG and TCGCACGCGTGGACC, FASN: CCCTTGATGAAGAGGGATCA
and ACTCCACAGGTGGGAACAAG, cMyc: TAGTGCTGCATGAGGAGACA
and CATCAATTTCTTCCTCATCTTC, Cyclin-D1: ATTGTGCCATCCATGCG
and TAGATGCACAACTTCTCGGC). Levels of specific amplicons were analyzed
in three biological repeats and quantified relative to a standard curve comprising
serial cDNA dilutions. The mRNA values were normalized to housekeeping gene
(Rplp0). Cycling parameters: initial denaturation for 3 min at 95 °C, following 40
cycles of: denaturation for 10 s at 95 °C; annealing, extension, and read fluorescence
for 30 s at 60 °C; addition of melt curve step: 10 s at 95 °C, with increments of 0.5 °
C every 5 s between 65 and 95 °C.
Lipidomics sample preparation. Solvents for sample preparation, as well as for
chromatography (LC/MS grade acetonitrile, isopropanol, methanol, water, HPLC
grade chloroform) were purchased from Bio-Lab, Inc. Solvent composition is
provided as volume-to-volume ratio. Lipids were extracted with the 2:1 chloroform:
methanol solution according to the Folch method28. Phase separation in the extract
was achieved by the addition of equivalent water volume and centrifugation at
2000×g for 5 min. The upper and middle phases were removed by aspiration and
the lower phase was dried in the nitrogen flow. Lipid extract was re-dissolved in 1:1
isopropanol:methanol and stored for analysis.
LC/MS data acquisition. For the reversed-phase chromatographic separation,
Phenomenex Kinetex C-18-XB 150 mm column (3 mm i.d., 2 µm beads) was used.
The column compartment of HPLC was maintained at 65 °C, sample vials at 30 °C.
Mobile phase was composed of two solvent mixes as follows: A—60:40 acetonitrile:
water mix having 10 mM ammonium formate (HPLC grade, Sigma), B— 90:8:2
acetonitrile:isopropanol:water with 10 mM ammonium formate. For the solvent B,
ammonium formate was dissolved in corresponding water volume before mixing
with the organic solvents. The buffer loop in the autosampler was filled with 1:1
isopropanol:methanol. Mobile phase flow was 0.5 mL/min. Mobile phase compo-
sition was changing according to the following program with linear gradients: 0
min—15% B; 2 min—30% B; 2.5 min—48% B; 11 min—82% B; 11.5 min—99% B,
maintained until 14 min, and then switched back to 15% B and equilibrated for 2.5
min. Chromatographic eluent was analyzed by ESI–MS Thermo Orbitrap Q
Exactive mass spectrometer. Ion source supplied 50 a.u. of sheath gas flow and 20 a.
u. of auxiliary gas flow. Auxiliary gas and the ion transfer capillary were heated to
350 °C. S-Lens RF level was 80 a.u. Analysis was performed in polarity switching
mode with the negative mode voltage −3.5 kV, and the positive mode voltage +3.3
kV. Automatic gain control was tuned to 106, scanning range was from 120 to 1800
m/z with mass resolution 70,000 in both polarity modes. Tandem mass spectra for
the corresponding samples were acquired in the separate technical repeats with the
following parameters of data-dependent acquisition: isolation width 1.4 Da, max-
imum ion accumulation time prior to fragmentation 600 ms, normalized collision
energy 30 a.u., minimum AGC target 104, fixed first mass 50 Da, three fragmen-
tation spectra per one MS1 scan, multiple-charge ions exclusion, resolution 17,500
for MS1 and MS2 scans, no polarity switching.
Lipidomics. According to the LC/MS method, two primary types of ions were
detected in both polarity modes: protonated analytes and NH4+ adducts in the
positive mode; deprotonated analytes and HCOO− adducts in the negative mode.
Peak peaking and intensity calling were performed in XCMS45, 46. Stable repro-
ducibility of chromatograms allowed no peak alignment. A custom-made R script
was used to identify M+ 0 peaks. For further analysis, only M+ 0 peaks of lipid
compounds were considered, with the intensity not less than 5 × 105 in at least one
of samples. For lipid mass list, lipids from Lipid Mass Structure Database47 were
used together with a list of compounds created by a combination of hydrophilic
“head” structures with even-numbered fatty acids. Selected groups of peaks and
their natural carbon mass-isotopomer distributions were verified manually in
Maven software48, 49. Intensities in each sample were log-transformed and con-
verted to z-scores. Additionally, to compare intensity profiles between compounds,
second normalization to z-scores was applied to each row.
PCA was performed on normalized dataset. Together, first four principal
components represented 81% of variance. Space of these four principal
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components, each representing more than 10% of total variance, was used for
clustering of peak profiles. Clustering was performed with k-means algorithm for
three centers. Resulted clusters were attributed to specific groups of samples
according to the maximal intensity in the averaged profile.
Statistical analyses. At least three mice were analyzed in in vivo experiments.
Organoid were grown from a mix of at least three mice and cultured in three
independent biological repeats. All experiments were repeated at least twice. Sta-
tistical analyses were performed using two-tailed unpaired Student’s t test, where
*p < 0.05, **p < 0.005, ***p < 0.001. All quantifications display the mean of the data
and error bars represent ± s.e.m. Images were processed and analyzed using the
Imaris, ImageJ, FSC Express Flow Cytometry Data Analysis, and ZEN programs.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
The authors declare that all data supporting the findings of this study are available within
this article and its supplementary information files or from the corresponding author
upon reasonable request. The source data underlying Figs. 4c, 4g, 5d, 5g and
Supplementary Figs. 1e, 1j, 2a-b, 6a, 6b, 6d, 7a, 7b+d, 7c+8b, 7e+8a, 7f+8d, 8c are
provided as a Source Data file.
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